Cargando…
Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas
BACKGROUND: Pancreatic neuroendocrine tumors (PNETs) are a group of rare tumors. Chromogranin A (CgA) was considered as the most practical and useful serum tumor marker in PNET patients. But peripheral blood levels of CgA are not routinely tested in Chinese patients with PNETs. This study was to ass...
Autores principales: | Qiao, Xin-Wei, Qiu, Ling, Chen, Yuan-Jia, Meng, Chang-Ting, Sun, Zhao, Bai, Chun-Mei, Zhao, Da-Chun, Zhang, Tai-Ping, Zhao, Yu-Pei, Song, Yu-Li, Wang, Yu-Hong, Chen, Jie, Lu, Chong-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130880/ https://www.ncbi.nlm.nih.gov/pubmed/25099181 http://dx.doi.org/10.1186/1472-6823-14-64 |
Ejemplares similares
-
Chromogranin A: A Valuable Serum Diagnostic Marker for Non-Insulinoma Neuroendocrine Tumors of the Pancreas in a Chinese Population
por: Hong, Liwen, et al.
Publicado: (2020) -
Low accuracy of chromogranin A for diagnosing early-stage pancreatic neuroendocrine tumors
por: Tseng, Chao-Ming, et al.
Publicado: (2018) -
Plasma levels of acylated ghrelin in patients with insulinoma and expression of ghrelin and its receptor in insulinomas
por: Wu, Hai-Yan, et al.
Publicado: (2020) -
Significance of chromogranin A and synaptophysin in pancreatic neuroendocrine tumors
por: Tomita, Tatsuo
Publicado: (2020) -
Serum chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumors
por: Hijioka, Masayuki, et al.
Publicado: (2014)